An Innovative Canadian Pharmaceutical Company

Revenue Projected at $150,000,000 by 2025

Sponsored
Message: AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Is Building The Capacity For Anticipated Growth

AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Is Building The Capacity For Anticipated Growth

posted on Mar 21, 2022 11:00AM

Share
New Message
Please login to post a reply